Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up
Aim. To evaluate survival and mortality in antiphospholipid syndrome (APS) as well as prognostic factors of APS deterioration. Material and methods. We retrospectively studied 248 case histories of patients admitted to the Institute of Rheumatology for 8 years. Primary APS was diagnosed in 35 patien...
Κύριοι συγγραφείς: | T M Reshetnyak, Z S Alekberova, G P Kotelnikova, E N Alexandrova, E S Mack, S G Radenska-Lopovok, L A Kalashnikova, V A Nasonova |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | Russian |
Έκδοση: |
"Consilium Medicum" Publishing house
2003-05-01
|
Σειρά: | Терапевтический архив |
Θέματα: | |
Διαθέσιμο Online: | https://ter-arkhiv.ru/0040-3660/article/view/29375 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
ανά: Z S Alekberova, κ.ά.
Έκδοση: (2004-08-01) -
Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
ανά: I. A. Doroshkevich, κ.ά.
Έκδοση: (2004-06-01) -
ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
ανά: Tat’yana M Reshetnyak
Έκδοση: (2014-03-01) -
Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
ανά: D V Reshetnyak, κ.ά.
Έκδοση: (2004-05-01) -
ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
ανά: F. A. Cheldieva, κ.ά.
Έκδοση: (2020-04-01)